at Zacks.com (Tue, 4:40PM)
An Appeals court has overturned a lower court ruling that found Medtronic (MDT +0.2%) did not infringe on Boston Scientific (BSX -1.4%) CRT patents, and has remanded the case for further proceedings. The appeals court says the lower court relied on a "legally incorrect allocation of the burden of proof" and incorrectly construed the claim terms in the suit.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Zacks.com (Jan 22, 2015)
at Nasdaq.com (Jan 20, 2015)
at Zacks.com (Jan 15, 2015)
at Zacks.com (Jan 14, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs